Improving Health, Health Care and Quality of Life

DaVita to Present Three Abstracts for the International Society for Peritoneal Dialysis
Presentations on Enhancing Patient Outcomes to Be Featured at Meeting in Vancouver
PRNewswire-FirstCall
DENVER

DaVita Inc. , a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research , today announced that it will present three abstracts at the 3rd North American Chapter meeting of the International Society for Peritoneal Dialysis (ISPD) on August 27-29 in Vancouver, British Columbia.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

ISPD provides leading renal health care providers with the opportunity to advance their knowledge of peritoneal dialysis (PD) and to promote advancement of such knowledge through international meetings and scientific publications.

The presentations will highlight subjects critical to physicians, nurses and other practitioners in the field of PD, including:

  --  A DaVita  pilot program evaluating ESA use in PD patients and how to
      ensure patient adherence while maintaining hemoglobin outcomes;
  --  Access to Peritoneal Dialysis: Overcoming Obstacles for Uninsured,
      Unencountered Patients - a look at how changes in PD clinic
      infrastructure and the industry's perception would increase usage of
      this valuable treatment method;

  --  The Post-Peritonitis Checklist: Beyond Pharmacological Treatment - an
      analysis of the impact implementing a step-by-step checklist of
      pre-existing and innovative interventions into patient care practices
      resulted in reduced peritonitis rates.


"DaVita is committed to leading the renal community in seeking out new and innovative ways to improve clinical outcomes for patients with kidney disease," said Allen R. Nissenson MD, Chief Medical Officer at DaVita. "The three abstracts being presented at this meeting reflect DaVita's success in driving quality improvement for patients."

DaVita and DaVita Clinical Research are registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500 company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita has been recognized as the only FORTUNE 500 company on WorldBlu's annual List of Most Democratic Workplaces™. As of June 30, 2009, DaVita operated or provided administrative services at 1,493 outpatient dialysis facilities and acute units in approximately 700 hospitals located in 43 states and the District of Columbia, serving approximately 116,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials and its community programs, please visit www.davita.com.

First Call Analyst:
FCMN Contact: LeAnne.Zumwalt@davita.com

Photo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO
http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com

SOURCE: DaVita Inc.

CONTACT: Craig Handzlik of DaVita Inc., +1-310-536-2542,
Craig.Handzlik@DaVita.com


Contact Investor Relations

For media inquiries, please contact:

Media Kit

Kate Stabrawa
2000 16th Street
Denver, CO 80202
(303) 876-7527